Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.
Paratus Sciences has raised $100.0M in total funding. The most recent round was Series A. The last funding was announced in February 2023.
Paratus Sciences's investors include ARCH Venture Partners, Polaris Partners, Alexandria Venture Investments, EcoR1 Capital, Leaps by Bayer.
Paratus Sciences is headquartered in New York, United States.
Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.
Paratus Sciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Paratus Sciences — Funding & Investors." VCBacked, February 27, 2023, https://www.vcbacked.co/company/paratus-sciences. Accessed July 19, 2026.
VCBacked. (2023). Paratus Sciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/paratus-sciences
{{cite web |title=Paratus Sciences — Funding & Investors |url=https://www.vcbacked.co/company/paratus-sciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated